The present invention relates to: a novel compound having activity to GPR119 a preparation method therefor and a pharmaceutical composition comprising the compound as an active ingredient. More specifically, the present invention relates to: a compound a preparation method therefor and a pharmaceutical composition comprising the compound as an active ingredient, the compound being for treating and/or preventing metabolic disease such as diabetes by improving metabolism of lipid, which is a risk factor for chronic cardiovascular disease, while having an effective blood-glucose lowering action and a positive effect for pancreatic beta cells.La présente invention concerne : un nouveau composé ayant une activité pour GPR119 son procédé de préparation une composition pharmaceutique comportant le composé en tant que principe actif. De façon plus précise, la présente invention concerne : un composé son procédé de préparation une composition pharmaceutique comportant le composé en tant que principe actif, le composé étant pour le traitement et/ou la prévention de maladies métaboliques telles que le diabète par amélioration du métabolisme des lipides, qui est un facteur de risque pour une maladie cardiovasculaire chronique, tout en ayant une action de réduction de la glycémie et un effet positif sur les cellules bêta du pancréas.본 발명은GPR119 작용 활성을 갖는 신규 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 약제학적 조성물에 관한 것이다. 보다 상세하게는 효과적인 혈당강하작용 및 췌장베타세포에 대한 긍정적 효과를 지니면서 만성 심혈관계 위험인자인 지질대사를 개선시켜 당뇨병과 같은 대사성 질환의 치료 및/또는 예방용 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 약제학적 조성물에 관한 것이다.
